Drug intelligence / Profile preview

acetaminophen + butalbital + caffeine + codeine

Development stage
Approved
Lead developer
AbbVie
Modality
Small Molecules
Administration
Oral
01

Overview

**Acetaminophen + butalbital + caffeine + codeine** is an FDA-approved oral fixed-dose combination product used for the management of the symptom complex of tension or muscle contraction headache when non-opioid and other alternative treatments are inadequate. It combines **acetaminophen**, a non-opioid analgesic and antipyretic; **butalbital**, a barbiturate central nervous system depressant/sedative; **caffeine**, a methylxanthine central nervous system stimulant that can augment analgesic efficacy; and **codeine**, an opioid agonist analgesic. The exact mechanism by which the combination relieves tension headache is not fully established, but clinical effect is thought to arise from complementary analgesic, sedative, and adjuvant stimulant actions in the central nervous system. Because it contains both an opioid and a barbiturate, it carries important risks including addiction, abuse, misuse, overdose, medication-overuse headache, and acetaminophen-related hepatotoxicity.

Brand names
Fioricet with CodeinePhrenilin with Caffeine and Codeine
Other names
butalbital + acetaminophen + caffeine + codeinebutalbital, acetaminophen, caffeine, and codeine phosphate capsulescaffeine + acetaminophen + butalbital + codeine
02

Targets

AMPAR (AMPA receptor)MOR (Mu opioid receptor)GABRR (GABA-A receptor subunit rho)ADOR (Adenosine receptors)

Beyond the preview

Go deeper on acetaminophen + butalbital + caffeine + codeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + butalbital + caffeine + codeine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call